A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : MMP-2

Search Conditions:
Search Keyword : MMP-2
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: MMP-2
Appearance Frequency: 4611 time(s)
Long forms: 25

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
matrix metalloproteinase-2
(4577 times)
Neoplasms
(746 times)
MMP-9 (394 times)
VEGF (301 times)
TIMP-2 (239 times)
1990 Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties.
matrix metalloproteinase protein-2
(6 times)
Chemistry
(1 time)
AP (1 time)
CYR61 (1 time)
F-GLP-1 (1 time)
2003 [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
metalloproteinase genes-metalloproteinase-2
(3 times)
Pharmacology
(1 time)
ACE (1 time)
BTB (1 time)
CA19-9 (1 time)
2010 Association of polymorphisms of zinc metalloproteinases with clinical response to stem cell therapy.
mitochondrial membrane potential-2
(2 times)
Pharmacognosy
(1 time)
COX-2 (1 time)
IL-6 (1 time)
NF-kappaB (1 time)
2016 Quercetin Suppresses the Migration and Invasion in Human Colon Cancer Caco-2 Cells Through Regulating Toll-like Receptor 4/Nuclear Factor-kappa B Pathway.
MMP-2KO
(2 times)
Medicine
(1 time)
MMP-9 (2 times)
WT (2 times)
AAA (1 time)
2002 Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms.
MPO, metalloproteinase 2
(2 times)
Neoplasms
(1 time)
AUC (1 time)
CC (1 time)
M-CSF (1 time)
2019 Diagnostic Power of Cytokine M-CSF, Metalloproteinase 2 (MMP-2) and Tissue Inhibitor-2 (TIMP-2) in Cervical Cancer Patients Based on ROC Analysis.
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-matrix metalloproteinase-2
(1 time)
Neoplasms
(1 time)
CLs (1 time)
PEG (1 time)
2023 Doxorubicin-loaded liposomes surface engineered with the matrix metalloproteinase-2 cleavable polyethylene glycol conjugate for cancer therapy.
hydroxamate-matrix metalloproteinase-2
(1 time)
Molecular Biology
(1 time)
FEP (1 time)
MD (1 time)
RESP (1 time)
2004 Binding affinity of hydroxamate inhibitors of matrix metalloproteinase-2.
major metalloproteinases, gelatinase A, 72 kDa type IV collagenase
(1 time)
Molecular Biology
(1 time)
MMPs (1 time)
2006 Prominent expression of metalloproteinases in early stages of ovarian tumorigenesis.
10  matrix metalloproteinase inhibitor: inhibition of 72-kD type IV collagenase
(1 time)
Nephrology
(1 time)
MC (1 time)
MMP (1 time)
1997 Rat mesangial cells and matrix metalloproteinase inhibitor: inhibition of 72-kD type IV collagenase (MMP-2) and of cell proliferation.
11  matrix metalloproteinase-2; and -9
(1 time)
Biology
(1 time)
--- 2016 Casticin Inhibits A375.S2 Human Melanoma Cell Migration/Invasion through Downregulating NF-kappaB and Matrix Metalloproteinase-2 and -1.
12  MEK1/2-ERK1/2 pathway, metalloproteinase-II
(1 time)
Cardiology
(1 time)
LVSd (1 time)
2015 Cardioprotection by curcumin post-treatment in rats with established chronic kidney disease.
13  metal matrix proteinase 2
(1 time)
Neoplasms
(1 time)
SASH1 (1 time)
2020 SASH1 Suppresses the Proliferation and Invasion of Human Skin Squamous Cell Carcinoma Cells via Inhibiting Akt Cascade.
14  metalloproteinase-2 in complex with the inhibitor
(1 time)
Biochemistry
(1 time)
TIMP-2 (1 time)
2007 Serum tissue inhibitor of metalloproteinase-2 (TIMP-2) and matrix metalloproteinase-2 in complex with the inhibitor (MMP-2:TIMP-2) as prognostic markers in bladder cancer.
15  metalloproteinases, the M(r) 72,000 type IV collagenase
(1 time)
Neoplasms
(1 time)
MMPs (1 time)
1992 Expression of matrix metalloproteinase genes in transformed rat cell lines of high and low metastatic potential.
16  metastasis-related metalloproteinase-2
(1 time)
Neoplasms
(1 time)
HUVEC (1 time)
PTTG (1 time)
RT/PCR (1 time)
2006 Regulation of angiogenesis and invasion by human Pituitary tumor transforming gene (PTTG) through increased expression and secretion of matrix metalloproteinase-2 (MMP-2).
17  MMP-12, were also found extracellularly, associated with elastin-containing structures
(1 time)
Hematology
(1 time)
MMPs (1 time)
SMC (1 time)
WT (1 time)
1999 Temporal and topographic matrix metalloproteinase expression after vascular injury in mice.
18  MMP-2 Tg
(1 time)
Biochemistry
(1 time)
IPC (1 time)
MMPs (1 time)
2007 Transgenic MMP-2 expression induces latent cardiac mitochondrial dysfunction.
19  MMP-2-siRNA
(1 time)
Medicine
(1 time)
ADM (1 time)
2012 Involvement of MMP-2 in adriamycin resistance dependent on ERK1/2 signal pathway in human osteosarcoma MG-63 cells.
20  MMP-2/9 were attenuated in the RIPC group
(1 time)
Medicine
(1 time)
CPB (1 time)
cTnT (1 time)
2014 Activities of cardiac tissue matrix metalloproteinases 2 and 9 are reduced by remote ischemic preconditioning in cardiosurgical patients with cardiopulmonary bypass.
21  MMP-2/VEGFR-2 inhibitors, particularly 8d
(1 time)
Biochemistry
(1 time)
--- 2022 Targeting the interplay between MMP-2, CA II and VEGFR-2 via new sulfonamide-tethered isomeric triazole hybrids; Microwave-assisted synthesis, computational studies and evaluation.
22  MMP-9, and LMC19 expressed 72-kDa gelatinase
(1 time)
Neoplasms
(1 time)
MMP-9 (1 time)
1993 Effect of epidermal growth factor and transforming growth factor beta 1 on growth and invasive potentials of newly established rat bladder carcinoma cell lines.
23  MMPs; 72-kDa type IV collagenase
(1 time)
Critical Care
(1 time)
ARDS (1 time)
BALF (1 time)
1997 Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome.
24  modulates metalloprotease 2
(1 time)
Biochemistry
(1 time)
VEGF (1 time)
2012 Blocking alphavbeta3 integrin by a recombinant RGD disintegrin impairs VEGF signaling in endothelial cells.
25  Moreover, peptide 30 inactivated metalloproteinase-2
(1 time)
Therapeutics
(1 time)
--- 2011 RGD-modified endostatin peptide 30 derived from endostatin suppresses invasion and migration of HepG2 cells through the alphavbeta3 pathway.